1
Home
Companies

Aadi Bioscience

#9092

Rank

$94.89M

Marketcap

US United States

Country

Aadi Bioscience
Leadership team

Dr. Neil P. Desai Ph.D. (Founder, Pres, CEO, Sec. & Director)

Mr. Scott M. Giacobello CPA (CFO & Treasurer)

Mr. Brendan P. Delaney M.B.A. (Chief Operating Officer)

Products/ Services
Biopharma, Biotechnology, Life Science
Number of Employees
50 - 100
Headquarters
Pacific Palisades, California, United States
Established
2011
Company Registration
SEC CIK number: 0001422142
Revenue
5M - 20M
Traded as
AADI
Social Media
URL
https://aadibio.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
History

Founded in 2019, Aadi Bioscience Inc., (ABI) is a clinical stage biotechnology company located in the San Francisco Bay Area, focusing on the development of novel treatments for neglected diseases and disorders. Our unique approach combines deep biological expertise, novel technology platforms and cutting-edge analytics to discover and develop breakthrough therapies. At ABI, we are committed to developing innovative solutions to improve the lives of patients suffering from neglected diseases.

Mission
Our mission at Aadi Bioscience is to discover, develop and deliver innovative treatments for neglected diseases and disorders that enable patients to lead healthier and fuller lives.
Vision
Our vision at Aadi Bioscience is to become the leading biotechnology company in the development of treatments for neglected diseases and disorders.
Key Team

Mr. Bryan Ball (Chief Quality Officer & Sr. VP of Manufacturing Operations)

Ms. Marcy Graham (SVP of Investor Relations & Corp. Communications)

Mr. Stephen M. Rodin J.D. (Sr. VP of Legal & Gen. Counsel)

Mr. Raymond G. Steitz (Sr. VP of HR & Chief HR Officer)

Dr. Loretta M. Itri F.A.C.P., M.D. (Chief Medical Officer)

Recognition and Awards
Aadi Bioscience has been honored as one of the Top 10 Up and Coming Biotech Companies of 2020 by the Global Health Council.
References

https://in.investing.com/equities/aerpio-pharma

https://finance.yahoo.com/quote/AADI/profile?p=AADI

https://www.crunchbase.com/organization/aadi-bioscience

https://companiesmarketcap.com/

https://aadibio.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Aadi Bioscience
Leadership team

Dr. Neil P. Desai Ph.D. (Founder, Pres, CEO, Sec. & Director)

Mr. Scott M. Giacobello CPA (CFO & Treasurer)

Mr. Brendan P. Delaney M.B.A. (Chief Operating Officer)

Products/ Services
Biopharma, Biotechnology, Life Science
Number of Employees
50 - 100
Headquarters
Pacific Palisades, California, United States
Established
2011
Company Registration
SEC CIK number: 0001422142
Revenue
5M - 20M
Traded as
AADI
Social Media
URL
https://aadibio.com